Direct-to-Consumer Atrial Fibrillation Screening

To the Editor In response to the US Preventive Services Task Force recommendation statement on the insufficient evidence regarding benefits and harms of screening for atrial fibrillation with electrocardiography (ECG),¹ Mandrola and colleagues² discuss the potential harms and lack of efficacy of screening for atrial fibrillation. Although some physicians and physician groups may recommend this screening,³ we should be concerned that the general public may have easy access to this screening test, in addition to other screenings that lack clinical evidence and consensus, through direct-to-consumer (DTC) screening companies.